000 01406 a2200385 4500
005 20250517181439.0
264 0 _c20181211
008 201812s 0 0 eng d
022 _a1873-3476
024 7 _a10.1016/j.ijpharm.2017.10.027
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGholizadeh, Shima
245 0 0 _aE-selectin targeted immunoliposomes for rapamycin delivery to activated endothelial cells.
_h[electronic resource]
260 _bInternational journal of pharmaceutics
_cSep 2018
300 _a759-770 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAnti-Bacterial Agents
_xadministration & dosage
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Delivery Systems
_xmethods
650 0 4 _aE-Selectin
_xadministration & dosage
650 0 4 _aHuman Umbilical Vein Endothelial Cells
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLiposomes
650 0 4 _aMice
650 0 4 _aSirolimus
_xadministration & dosage
700 1 _aVisweswaran, Ganesh Ram R
700 1 _aStorm, Gert
700 1 _aHennink, Wim E
700 1 _aKamps, Jan A A M
700 1 _aKok, Robbert J
773 0 _tInternational journal of pharmaceutics
_gvol. 548
_gno. 2
_gp. 759-770
856 4 0 _uhttps://doi.org/10.1016/j.ijpharm.2017.10.027
_zAvailable from publisher's website
999 _c27690733
_d27690733